Antirheumatic Drugs May Be Linked to Pulmonary Toxicity & More Michele B. Kaufman, PharmD, BCGP | June 24, 2015At a recent symposium, Kristin Highland, MD, reported on the use of antirheumatic treatments, specifically methotrexate, and their connections with pulmonary toxicity in patients.
2014 ACR/ARHP Annual Meeting: Methotrexate Use in Patients with RA Susan Bernstein | April 1, 2015Review of clinical research on methotrexate therapy, effect on patients’ functionality, tolerability, adverse events
Does Gastric Bypass Result in Reduced Absorption of Methotrexate? Iris Zink, NP | March 1, 2015Data suggest changes in physiology of the gut post-bariatric surgery may result in medication malabsorption of immunosuppressive drugs
Rheumatology Outreach in Macedonia Carole Dodge, OT, CHT | October 1, 2014Occupational therapist Carole Dodge, OT, CHT, describes experience providing hand therapy to patients with arthritis, rheumatic disease
Decernotinib, Subcutaneous Methotrexate Drug Updates, Trials, Approvals Michele B. Kaufman, PharmD, BCGP | October 1, 2014Plus, rheumatology drug news, safety updates
Vaccinations for Immunocompromised Patients Are Shared Responsibility of Specialists, Primary Care Physicians Kathy Holliman | September 1, 2014Infectious Diseases Society of America recommends both physician groups educate patients, household members on importance of vaccines
Coding Corner Question: September Staff | September 1, 2014Coding for first infliximab infusion in patient with rheumatoid arthritis
Drugs Studied for Use in Rheumatoid Arthritis, Weight Loss Michele B. Kaufman, PharmD, BCGP | August 1, 2014Plus, rheumatology drug news from EULAR 2014
EULAR 2014: Non-Tumor Necrosis Factor Biologics Update Thomas R. Collins | August 1, 2014Clinical trials on rheumatology drugs, including sarilumab, show promise for patients with rheumatoid arthritis also taking methotrexate
EULAR 2014: Research on Rheumatoid Arthritis, Spondyloarthritis Thomas R. Collins | August 1, 2014Latest findings on rheumatological drug therapies, including methotrexate for RA, tumor necrosis factor inhibitors for SpA